Clinical Trial Update: Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial evaluated the efficacy, safety, and pharmacokinetics of daridorexant in children aged 10 to under 18 with insomnia disorder; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Daridorexant (daridorexant)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Insomnia | Phase 2 | Status: COMPLETED